Perikabiven Injection, Emulsion
Product Images NDC 63323-714

29 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 29 technical images submitted to the FDA as part of the official labeling for Perikabiven (NDC 63323-714). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Per0e 0005 01)

Figure (Per0e 0005 01)
An instructional diagram illustrating the internal compartments of a Perikabiven injection emulsion bag. It shows separated sections labeled 'Lipids' and 'Amino Acids' with arrows indicating mixing into 'Dextrose'. Numbered indicators point to various bag components, including connectors and an air vent, detailing the setup for intravenous administration.*
FDA Label Image

Figure (Per0e 0005 02)

Figure (Per0e 0005 02)
An instructional illustration showing how to combine components of Perikabiven intravenous emulsion. The diagram depicts the separate compartments labeled 'Dextrose,' 'Amino Acids,' and 'Lipids' being mixed by directing the contents downward and then shaking the bag to blend the three components into one homogeneous emulsion solution for intravenous administration.*
FDA Label Image

Figure (Per0e 0005 03)

Figure (Per0e 0005 03)
An instructional three-panel illustration showing preparation steps for Perikabiven intravenous emulsion injection. The first panel depicts a fluid bag with separate compartments labeled Dextrose, Amino Acids, and Lipids, with two hands positioned below. The second panel shows hands pressing the compartments upward with arrows indicating movement. The third panel demonstrates one hand twisting or breaking a component of the bag. The images guide proper handling of the multi-chamber bag before use.*
FDA Label Image

Figure (Per0e 0005 04)

Figure (Per0e 0005 04)
Instructional two-panel illustration showing steps to use a medical fluid bag. The first panel depicts a hand holding the bag's port, preparing to access it. The second panel shows a hand attaching or detaching a connector or syringe to the bag's port for intravenous use.*
FDA Label Image

Figure (Per0e 0005 05)

Figure (Per0e 0005 05)
An instructional illustration showing a three-step process involving a medical infusion bag. The first two panels depict hands preparing the bag by manipulating an injection port or connector. The third panel shows the bag hanging on a hook with an attached infusion line, indicating setup for intravenous administration.*
FDA Label Image

Figure 1 (Per0e 0005 06)

Figure 1 (Per0e 0005 06)
A cumulative incidence function plot comparing Intralipid and 4-Oil Mixed Lipid over 84 study days. The y-axis shows the cumulative incidence function, while the x-axis represents study days. The chart includes the number of subjects with events and the number censored at various time points, with data plotted for both groups along with censored data markers and confidence intervals.*
FDA Label Image

Figure (Per0e 0005 07)

Figure (Per0e 0005 07)
Chemical structure diagram of a glucose molecule with a water molecule illustrating a hydrated form, consistent with Dextrose, one of the active ingredients in Perikabiven injection emulsion by Fresenius Kabi USA, LLC.*
FDA Label Image

Figure (Per0e 0005 08)

Figure (Per0e 0005 08)
Perikabiven injection, emulsion, is displayed in a clear container with a brown cap. The label includes the proprietary name Perikabiven, identifies it as an intravenous injection with multiple amino acids and nutrients, and shows it is manufactured by Fresenius Kabi USA, LLC. The packaging includes handling and storage details and cautionary information in multiple languages.*
FDA Label Image

Figure (Per0e 0005 09)

Figure (Per0e 0005 09)
Chemical structure of the molecule imidazole, commonly represented by a five-membered ring containing two nitrogen atoms at non-adjacent positions.*
FDA Label Image

Figure (Per0e 0005 10)

Figure (Per0e 0005 10)
Chemical structure of Perikabiven, an intravenous injection emulsion containing Dextrose, Soybean oil, Electrolytes, and various amino acids including Lysine, Phenylalanine, Leucine, Valine, Threonine, Methionine, Isoleucine, Tryptophan, Alanine, Arginine, Glycine, Proline, Histidine, Glutamic Acid, Serine, Aspartic Acid, and Tyrosine as active ingredients.*
FDA Label Image

Figure (Per0e 0005 11)

Figure (Per0e 0005 11)
Chemical structure of 1-pyrrolidinecarboxylic acid, identified as proline, an amino acid included in the Perikabiven injection emulsion.*
FDA Label Image

Figure (Per0e 0005 12)

Figure (Per0e 0005 12)
Chemical structure diagram depicting a molecule with a benzene ring attached to a chain ending with a carboxylic acid group and an amino group (NH2). This structure corresponds to the molecular formula of an amino acid component often found in pharmaceutical formulations.*
FDA Label Image

Figure (Per0e 0005 13)

Figure (Per0e 0005 13)
Chemical structure diagram of Perikabiven illustrating the molecular arrangement of its constituent components, including various amino acids and other chemical groups, depicted with chemical bonds and atom symbols (C, H, O, N).*
FDA Label Image

Figure (Per0e 0005 14)

Figure (Per0e 0005 14)
Chemical structure diagram of an amino acid molecule, showing its backbone and side chain groups with labeled atoms including carbon (C) and oxygen (O).*
FDA Label Image

Figure (Per0e 0005 15)

Figure (Per0e 0005 15)
Chemical structure diagram showing the molecular formula of the active ingredients in Perikabiven, with carbon, hydrogen, and oxygen atoms depicted in a detailed structural formula.*
FDA Label Image

Figure (Per0e 0005 16)

Figure (Per0e 0005 16)
Chemical structure diagram of the active ingredient in Perikabiven. The image shows a two-dimensional molecular formula with carbon, hydrogen, and oxygen atoms connected by single and double bonds, representing a part of the compound's chemical makeup.*
FDA Label Image

Figure (Per0e 0005 17)

Figure (Per0e 0005 17)
Chemical structure diagram showing a molecular structure of an active ingredient, featuring carbon, hydrogen, and oxygen atoms arranged in a complex framework with multiple branching chains.*
FDA Label Image

Figure (Per0e 0005 18)

Figure (Per0e 0005 18)
Chemical structure diagram depicting the molecular arrangement of the active ingredient mixture in Perikabiven injection, emulsion. The structure shows atoms and bonds consistent with amino acids and lipids present in the formulation by Fresenius Kabi USA, LLC.*
FDA Label Image

Figure (Per0e 0005 19)

Figure (Per0e 0005 19)
Chemical structure diagram depicting the molecular formula of a compound, showing carbon (C), hydrogen (H), and oxygen (O) atoms arranged in a chain with multiple bonds and side groups, consistent with a fatty acid or lipid type molecule.*
FDA Label Image

Figure (Per0e 0005 20)

Figure (Per0e 0005 20)
Chemical structure diagram depicting the molecular formula of the active ingredient in Perikabiven injection, emulsion. The diagram shows atoms and bonds arranged in a complex structure, consistent with the detailed composition of the product's amino acids and compounds.*
FDA Label Image

Figure (Per0e 0005 21)

Figure (Per0e 0005 21)
Chemical structure diagram depicting a complex molecule with nitrogen (N), oxygen (O), and carbon (C) atoms, illustrating peptide-like bonds and side chains. The image likely represents the structure of an amino acid or small peptide-related compound, consistent with components of the generic ingredients list of Perikabiven injection emulsion.*
FDA Label Image

Figure (Per0e 0005 22)

Figure (Per0e 0005 22)
Chemical structure diagram of Phosphatidylcholine, showing the molecular arrangement of atoms including carbon, hydrogen, oxygen, phosphorus, and nitrogen in its chemical formula.*
FDA Label Image

Figure (Per0e 0005 23)

Figure (Per0e 0005 23)
Chemical structure of phosphatidylethanolamine shown as a molecular diagram with labeled functional groups and atoms.*
FDA Label Image

Figure (Per0e 0005 24)

Figure (Per0e 0005 24)
Chemical structure of the active ingredient showing a molecular diagram with carbon, hydrogen, and oxygen atoms, including a hydroxyl group and a ring structure indicative of a sugar molecule.*
FDA Label Image

Fresenius Kabi Logo (Per0e 0005 25)

Fresenius Kabi Logo (Per0e 0005 25)
Perikabiven injection, emulsion in a 100 mL IV bag, containing amino acids, electrolytes, dextrose, and soybean oil. The label displays the Fresenius Kabi logo and identifies the product as a human prescription drug for intravenous use. The bag features typical pharmacy labeling information including directions for use and NDC 63323-714, manufactured by Fresenius Kabi USA, LLC.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
Label for Perikabiven injectable emulsion, 1440 mL, by Fresenius Kabi USA, LLC. This intravenous amino acids, electrolytes, dextrose, and lipid emulsion is for peripheral infusion. The label includes activation and usage instructions, ingredient details, additive compatibility, storage guidelines, and port identification diagrams. NDC 63323-714.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
Perikabiven 4 x 1440 mL injection emulsion label showing amino acids, electrolytes, dextrose, and lipid injectable emulsion for intravenous use. The label indicates sterile single dose containers, storage instructions (store at 5°C to 25°C), and no sulfites added. Manufactured by Fresenius Kabi USA, LLC in Uppsala, Sweden, the label includes contact information and barcodes for product identification.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
Label for Perikabiven 1920 mL intravenous injection emulsion. It is an amino acids, electrolytes, dextrose, and lipid injectable emulsion for peripheral infusion. Manufactured by Fresenius Kabi USA, LLC. The label includes volume markings and instructions for activating the bag, additive port, and infusion port. It also provides nutritional content, storage recommendations, and contains a barcode with the NDC 63323-714.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
Label for Perikabiven injection, an amino acids, electrolytes, dextrose, and lipid injectable emulsion for intravenous use. The package contains 4 bottles of 1920 mL each. The label states it is a sterile single dose container, for peripheral infusion, with no sulfites added. Storage instructions and ordering information are included. Manufactured by Fresenius Kabi in Uppsala, Sweden, with a batch number and manufacture dates visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.